BAP1,PBRM1andSETD2in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies-Reference-Cited by-同舟云学术

BAP1,PBRM1andSETD2in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies

Published:2015-07-11 Issue:9 Volume:15 Page:1201-1210
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Piva Francesco,Santoni Matteo,Matrana Marc R,Satti Suma,Giulietti Matteo,Occhipinti Giulia,Massari Francesco,Cheng Liang,Lopez-Beltran Antonio,Scarpelli Marina,Principato Giovanni,Cascinu Stefano,Montironi Rodolfo

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/14737159.2015.1068122

Reference63 articles.

1. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

2. Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

3. Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

4. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

5. Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequent gene mutations and the correlations with clinicopathological features in clear cell renal cell carcinoma: preliminary study based on Chinese population and TCGA database;BMC Urology;2024-08-09

2. Advancements in Radiogenomics for Clear Cell Renal Cell Carcinoma: Understanding the Impact of BAP1 Mutation;Journal of Clinical Medicine;2024-07-06

3. Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study;Cancer Reports;2024-06

4. A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature review;Diagnostic Pathology;2024-05-10

5. Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma;Annals of Diagnostic Pathology;2024-02